Home | All intervention

[RDF data]
Intervention #100366 (Drug:Olanzapine and Fluoxetine combination)

Resource URI: http://static.linkedct.org/resource/intervention/100366
linkedct:description Open label acute phase: introductory dose for 4 days then 3/25, 6/25, 12/25, 6/50, 12/50 or 18/50mg, oral, daily, for 6-8 weeks. Open label stabilization phase: 6/25, 12/25, 6/50, 12/50 or 18/50 mg, oral, daily for 16-20 weeks. Double blind relapse prevention phase: dose determined during stabilization phase at week 17, oral, daily, for 27 weeks.
is linkedct:intervention of <http://static.linkedct.org/resource/trials/NCT00958568>
linkedct:intervention_id 100366 (xsd:int)
linkedct:intervention_name Olanzapine and Fluoxetine combination
linkedct:intervention_type Drug
rdfs:label Intervention #100366 (Drug:Olanzapine and Fluoxetine combination)
rdf:type linkedct:intervention